Clinical Journal of Gastroenterology

, Volume 12, Issue 2, pp 176–181 | Cite as

Chronic intestinal pseudo-obstruction due to al amyloidosis: a case report and literature review

  • Tomoya IidaEmail author
  • Daisuke Hirayama
  • Gota Sudo
  • Kei Mitsuhashi
  • Hisayoshi Igarashi
  • Kentaro Yamashita
  • Hiroo Yamano
  • Hiroshi Nakase
Case Report


A 59-year-old woman presented to our hospital with a 6-month history of nausea, weight loss, and abdominal distension. Physical examination revealed abdominal distension without tenderness, and edema, numbness, and multiple peripheral neuropathy in the limbs. Blood test results showed anemia, hypoproteinemia, and hypoalbuminemia. Immunoelectrophoresis detected kappa-type Bence-Jones protein in both the serum and urine. Bone marrow examination did not reveal an increase of plasma cells. Computed tomography showed intestinal distension and retention of intestinal contents. No obstructive intestinal lesions were observed. Lower gastrointestinal endoscopy showed a decrease in the vascular visibility of the rectal mucosa. Histological findings showed amyloid deposition, which was positive for amyloid light-chain (AL) κ. Thus, she was diagnosed with chronic intestinal pseudo-obstruction (CIPO) due to gastrointestinal and neurological involvement of AL amyloidosis. Her abdominal symptoms were gradually improved by the insertion of an ileus tube and medication. Although we recommended chemotherapy for stopping her disease progression, she did not want to receive it. She died 1 year later because of her pneumonia. We should keep in mind that amyloidosis is an important cause of CIPO. Histopathological examination by endoscopic biopsy is required for exact diagnosis and appropriate treatment for CIPO due to amyloidosis.


Pseudo-obstruction Ileus Amyloidosis 


Compliance with ethical standards

Conflict of interest

Tomoya Iida, Daisuke Hirayama, Gota Sudo, Kei Mitsuhashi, Hisayoshi Igarashi, Kentaro Yamashita, Hiroo Yamano, and Hiroshi Nakase declare that they have no conflict of interest.

Research involving human and/or animal participants

All procedures followed have been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.

Informed consent

Informed consent was obtained from this patient for being described in this case report.


  1. 1.
    Dudley HA, Sinclair IS, McLaren IF, et al. Intestinal pseudo-obstruction. J R Coll Surg Edinb. 1958;3:206–17.Google Scholar
  2. 2.
    Stanghellini V, Cogliandro RF, de Giorgio R, et al. Chronic intestinal pseudo-obstruction; manifestations, natural history and management. Neurogastroenterol Motil. 2007;19:440–52.CrossRefGoogle Scholar
  3. 3.
    Connor FL, Di Lorenzo C. Chronic intestinal pseudo-obstruction: assessment and management. Gastroenterology. 2006;130:29–36.CrossRefGoogle Scholar
  4. 4.
    Sipe JD, Benson MD, Buxbaum JN, et al. Nomenclature 2014: amyloid fibril proteins and clinical classification of the amyloidosis. Amyloid. 2014;21:221–4.CrossRefGoogle Scholar
  5. 5.
    Iida T, Yamano H, Nakase H. Systemic amyloidosis with gastrointestinal involvement: diagnosis from endoscopic and histological views. J Gastroenterol Hepatol. 2018;33:583–90.CrossRefGoogle Scholar
  6. 6.
    Tada S, Iida M, Iwashita A, et al. Endoscopic and biopsy findings of the upper digestive tract in patients with amyloidosis. Gastrointest Endosc. 1990;36:10–4.CrossRefGoogle Scholar
  7. 7.
    Lim AY, Lee JH, Jung KS, et al. Clinical features and outcomes of systemic amyloidosis with gastrointestinal involvement: a single-center experience. Korean J Intern Med. 2015;30:496–505.CrossRefGoogle Scholar
  8. 8.
    Freudenthaler S, Hegenbart U, Schönland S, et al. Amyloid in biopsies of the gastrointestinal tract—a retrospective observational study on 542 patients. Virchows Arch. 2016;468:569–77.CrossRefGoogle Scholar
  9. 9.
    Briggs GW. Amyloidosis. Ann Intern Med. 1961;55:943–57.CrossRefGoogle Scholar
  10. 10.
    Yilmaz M, Unsal A, Sokmen M, et al. Duodenal biopsy for diagnosis of renal involvement in amyloidosis. Clin Nephrol. 2012;77:114–8.CrossRefGoogle Scholar
  11. 11.
    Hayman SR, Lacy MQ, Kyle RA, et al. Primary systemic amyloidosis: a cause of malabsorption syndrome. Am J Med. 2001;111:535–40.CrossRefGoogle Scholar
  12. 12.
    Milivojevic V, Stojanovic M, Rankovic I, et al. Multiple myeloma associated intestinal amyloidosis: intestinal pseudoobstruction falsely considered as an ascites. Rev Recent Clin Trials. 2018;13:79–81.CrossRefGoogle Scholar
  13. 13.
    Leong RY, Nio K, Plumley L, et al. Systemic amyloidosis causing intestinal hemorrhage and pseudo-obstruction. J Surg Case Rep. 2014. Google Scholar
  14. 14.
    Kim YJ, Kim HS, Park SY, et al. Intestinal amyloidosis with intractable diarrhea and intestinal pseudo-obstruction. Korean J Gastroenterol. 2012;60:172–6.CrossRefGoogle Scholar
  15. 15.
    Liapis K, Michelis FV, Delimpasi S, et al. Intestinal pseudo-obstruction associated with amyloidosis. Amyloid. 2011;18:76–8.CrossRefGoogle Scholar
  16. 16.
    Fonnesu C, Giovinale M, Verrecchia E, et al. Gastrointestinal amyloidosis: a case of chronic diarrhoea. Eur Rev Med Pharmacol Sci. 2009;13:45–50.Google Scholar
  17. 17.
    Hurlstone DP. Iron-deficiency anemia complicating AL amyloidosis with recurrent small bowel pseudo-obstruction and hindgut sparing. J Gastroenterol Hepatol. 2002;17:623–4.CrossRefGoogle Scholar
  18. 18.
    Deguchi M, Shiraki K, Okano H, et al. Primary localized amyloidosis of the small intestine presenting as an intestinal pseudo-obstruction: report of a case. Surg Today. 2001;31:1091–3.CrossRefGoogle Scholar
  19. 19.
    Kanai H, Kashiwagi M, Hirakata H, et al. Chronic intestinal pseudo-obstruction due to dialysis-related amyloid deposition in the propria muscularis in a hemodialysis patient. Clin Nephrol. 2000;53:394–9.Google Scholar
  20. 20.
    Hiramatsu K, Kaneko S, Shirota Y, et al. Gastrointestinal amyloidosis secondary to hypersensitivity vasculitis presenting with intestinal pseudoobstruction. Dig Dis Sci. 1998;43:1824–30.CrossRefGoogle Scholar
  21. 21.
    Borczuk A, Mannion C, Dickson D, et al. Intestinal pseudo-obstruction and ischemia secondary to both beta 2-microglobulin and serum A amyloid deposition. Mod Pathol. 1995;8:577–82.Google Scholar
  22. 22.
    Fraser AG, Arthur JF, Hamilton I. Intestinal pseudoobstruction secondary to amyloidosis responsive to cisapride. Dig Dis Sci. 1991;36:532–5.CrossRefGoogle Scholar
  23. 23.
    Tada S, Iida M, Yao T, et al. Intestinal pseudo-obstruction in patients with amyloidosis: clinicopathologic differences between chemical types of amyloid protein. Gut. 1993;34:1412–7.CrossRefGoogle Scholar
  24. 24.
    Gertz MA. Immunoglobulin light chain amyloidosis diagnosis and treatment algorithm 2018. Blood Cancer J. 2018;8:44.CrossRefGoogle Scholar
  25. 25.
    Westermark GT, Fändrich M, Westermark P. AA amyloidosis: pathogenesis and targeted therapy. Annu Rev Pathol. 2015;10:321–44.CrossRefGoogle Scholar
  26. 26.
    Amiot A, Jolly F, Alves A, et al. Long-term outcome of chronic intestinal pseudo-obstruction adult patients requiring home parenteral nutrition. Am J Gastroenterol. 2009;104:1262–70.CrossRefGoogle Scholar
  27. 27.
    Pironi L, Joly F, Forbes A, et al. Long-term follow-up of patients on home parenteral nutrition in Europe: implication for intestinal transplantation. Gut. 2011;60:17–25.CrossRefGoogle Scholar
  28. 28.
    Rao AS, Camilleri M. Metoclopramide and tardive dyskinesia. Aliment Pharmacol Ther. 2010;31:11–9.CrossRefGoogle Scholar
  29. 29.
    Emmanuel AV, Shand AG, Kamm MA. Erythromycin for the treatment of chronic intestinal pseudo-obstruction: description of six cases with a positive response. Aliment Pharmacol Ther. 2004;19:687–94.CrossRefGoogle Scholar
  30. 30.
    O’Dea CJ, Brookes JH, Wattchow DA. The efficacy of treatment of patients with severe constipation or recurrent pseudo-obstruction with pyridostigmine. Colorectal Dis. 2010;12:540–8.CrossRefGoogle Scholar
  31. 31.
    Emmanuel AV, Kamm MA, Roy AJ, et al. Randomised clinical trial: the efficacy of prucalopride in patients with chronic intestinal pseudo-obstruction—a double-blind, placebo-controlled, cross-over, multiple n = 1 study. Aliment Pharmacol Ther. 2012;35:48–55.CrossRefGoogle Scholar
  32. 32.
    Ohkubo H, Fuyuki A, Arimoto J, et al. Efficacy of percutaneous endoscopic gastro-jejunostomy (PEG-J) decompression therapy for patients with chronic intestinal pseudo-obstruction (CIPO). Neurogastroenterol Motil. 2017. Scholar

Copyright information

© Japanese Society of Gastroenterology 2018

Authors and Affiliations

  1. 1.Department of Gastroenterology and HepatologySapporo Medical University School of MedicineSapporoJapan

Personalised recommendations